International audienceHistone deacetylases (HDACs) are a family of enzymes found in bacteria, fungi, plants, and animals that profoundly affect cellular function by catalyzing the removal of acetyl groups from -N-acetylated lysine residues of various protein substrates including histones, transcription factors, alpha-tubulin, and nuclear importers. Although the precise roles of HDAC isoforms in cellular function are not yet completely understood, inhibition of HDAC activity has emerged as a promising approach for reversing the aberrant epigenetic states associated with cancer and other chronic diseases. Potent new isoform-selective HDAC inhibitors would therefore help expand our understanding of the HDAC enzymes and represent attractive lea...
The first part of this work describes the synthesis of a new histone deacetylase (HDAC) inhibitor (H...
Histone Deacetylases are considered promising targets for cancer epigenetic therapy, and small molec...
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play imp...
International audienceHistone deacetylases (HDACs) are a family of enzymes found in bacteria, fungi,...
The broad study of histone deacetylases in chemistry, biology and medicine relies on tool compounds ...
Today, we are witnessing an explosion of scientific concepts in cancer chemotherapy. It has been con...
Reversible lysine acetylation serves as a critical regulatory pathway for diverse cellular processes...
Alteration and abnormal epigenetic mechanisms can lead to the aberration of normal biological functi...
In humans, the zinc-dependent histone deacetylases (HDACs) are a family of 11 nonredundant isoforms ...
Histone Deacetylases (HDACs) are among the most attractive and interesting targets in anticancer dru...
Inappropriate epigenetic modifications of gene expression are associated with malignant phenotype an...
Histone deacetylases (HDACs) are epigenetic targets with an important role in cancer, neurodegenerat...
The human genome is contained in chromatin, which is a complex macromolecular complex. It is made of...
Metal-dependent histone deacetylases (HDACs) catalyze the hydrolysis of acetyl l-lysine side chains ...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
The first part of this work describes the synthesis of a new histone deacetylase (HDAC) inhibitor (H...
Histone Deacetylases are considered promising targets for cancer epigenetic therapy, and small molec...
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play imp...
International audienceHistone deacetylases (HDACs) are a family of enzymes found in bacteria, fungi,...
The broad study of histone deacetylases in chemistry, biology and medicine relies on tool compounds ...
Today, we are witnessing an explosion of scientific concepts in cancer chemotherapy. It has been con...
Reversible lysine acetylation serves as a critical regulatory pathway for diverse cellular processes...
Alteration and abnormal epigenetic mechanisms can lead to the aberration of normal biological functi...
In humans, the zinc-dependent histone deacetylases (HDACs) are a family of 11 nonredundant isoforms ...
Histone Deacetylases (HDACs) are among the most attractive and interesting targets in anticancer dru...
Inappropriate epigenetic modifications of gene expression are associated with malignant phenotype an...
Histone deacetylases (HDACs) are epigenetic targets with an important role in cancer, neurodegenerat...
The human genome is contained in chromatin, which is a complex macromolecular complex. It is made of...
Metal-dependent histone deacetylases (HDACs) catalyze the hydrolysis of acetyl l-lysine side chains ...
Histone deacetylase (HDAC) proteins have become an important target for the treatment of several dis...
The first part of this work describes the synthesis of a new histone deacetylase (HDAC) inhibitor (H...
Histone Deacetylases are considered promising targets for cancer epigenetic therapy, and small molec...
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play imp...